Study Summary
This trial will study the safety and effectiveness of a new DIPG treatment combining ultrasound and chemotherapy in children.
- Brain Tumor
Treatment Effectiveness
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: 2 years
Trial Safety
Trial Design
1 Treatment Group
Blood Brain Barrier Disruption (BBBD)
1 of 1
Experimental Treatment
3 Total Participants · 1 Treatment Group
Primary Treatment: Blood Brain Barrier Disruption (BBBD) · No Placebo Group · Phase 1 & 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 5 - 18 · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there still opportunities to participate in this research endeavor?
"Data listed on clinicaltrials.gov demonstrates that this research is actively seeking to enrol participants. Initially published on the 10th of December 2022 and last modified 18 days later, it is now available for volunteers." - Anonymous Online Contributor
What is the maximum capacity of participants in this medical study?
"Yes, the information on clinicialtrials.gov indicates that this trial is actively recruiting subjects. It was initially published on December 10th 2022 and has been updated as recently as November 18th 2022. The study requires 3 participants to be found at 1 medical institution." - Anonymous Online Contributor
Is it possible for individuals younger than 35 to enroll in this clinical trial?
"This research opportunity is open to participants aged between 5 and 18 years old." - Anonymous Online Contributor
To which demographic is eligibility for this experiment restricted?
"This clinical trial seeks 3 juvenile and adolescent patients who have been diagnosed with DIPG. To be eligible for the study, candidates must meet a number of conditions: Age between 5 to 18 years old; Completion of radiation therapy no longer than 12 weeks ago; No evidence on post-radiation imaging contraindicating MRgFUS; Capacity to attend all visits and life expectancy over 6 months; Ability or legal guardianship capacity to provide consent/assent, if applicable; Steroid dose stability for at least 7 days preceding enrollment (if steroids are in use); At least 14 days passed since any previous brain surgery with full" - Anonymous Online Contributor